| |
Veröffentlichungen zum Thema:
Böhme, T.M.; Keim, C.; Dannhardt, G.;
Mutschler, E.; Lambrecht, G.: Structure - Activity Relationships
of Dimethindene Derivatives as New M2-Selective Muscarinic Receptor
Antagonists, J. Med. Chem. 2003; 46, 856-867
Böhme, T.M.; Keim, C.; Dannhardt, G.; Lambrecht,
G.; Mutschler, E.: Design and Pharmacology of Quinuclidine Derivatives
as M2-Selective Muscarinic Receptor Ligands, Bioorg. Med. Chem.
Lett. 2001; 11; 1241-1243
Tumiatti, V.; Wehrle, J.; Hildebrandt, C.; Moser,
U.; Dannhardt, G.; Mutschler, E.; Lambrecht, G.: Muscarinic properties
of compounds related to arecaidine propargyl ester, Arzneim. Forsch.
/ Drug Res. 2000; 50 (I),1, 11-15
Dannhardt, G.; Lambrecht, G.; Laufer, S.; Mutschler,
E.; Schweiger, J.: Regioisomeric 5(3)-Aminomethyl-3(5)-Phenyl Isoxazoles:
Synthesis, Spectroscopic Discrimination and Muscarinic Potency,
Arch. Pharm. (Weinheim), 1995; 328; 437-443
Dannhardt, G.; Kiefer, W.; Lambrecht, G.; Laufer
S.; Mutschler, E.; Schweiger, J.; Striegel, H. G.: Regioisomeric
3-, 4- and 5-Aminomethyl Isoxazoles: Synthesis and muscarinic activity.
In: Eur. J. Med. Chem. 1995; 839-850
Dannhardt, G.; Lambrecht, G.; Laufer, S.; Mutschler,
E.; Schweiger; J.: 3-Methyl-5- trimethylammoniummethyl-1,2,4-oxadiazole
iodide: Highly efficient synthesis and muscarinic activity using
functional models. In: Pharm. Pharmacol. Lett. 1995; 60-62
|
|
